Registering with medwireNews allows you to personalize your medwireNews homepage and receive eAlerts for your chosen news services.
Email address:
Remember my details 
2 dot4
02 July 2015    General neurology
A longitudinal study of people with autosomal dominant Alzheimer’s disease shows that β-amyloid deposition begins well before neurodegeneration and cognitive decline.
02 July 2015    Cardiology
Analysis of the REVEAL registry shows poor 5-year outcomes for patients with pulmonary arterial hypertension, despite improvements due to targeted therapies.
01 July 2015    General neurology
Marked reductions in cognitive performance are present up to 18 years before people develop Alzheimer’s disease dementia, research shows.
01 July 2015    Psychiatry
Almost half of patients with bipolar disorder will have comorbid anxiety disorder in their lifetime, show the findings of a systematic review and meta-analysis.
29 June 2015    Infectious Diseases
The level of serum duplex-linear DNA increases markedly with liver disease progression and development of hepatocellular carcinoma in patients with chronic hepatitis B virus (HBV) infection, suggests research published in Gut.
29 June 2015    Infectious Diseases
Hepatic alanine aminotransferase flares are associated with rapid decline and greater annual reductions of hepatitis B surface antigen in patients with chronic hepatitis B virus infection who achieve HBsAg seroclearance, say Japanese researchers.
26 June 2015    Gynecology
Addition of bevacizumab to first-line platinum-based chemotherapy does not improve overall survival in women with ovarian cancer, according to the mature data of the ICON7 trial.
22 June 2015    General neurology
A study comparing outcomes among patients treated with first-line lorazepam, midazolam or clonazepam for status epilepticus finds that the three drugs are broadly equivalent.
22 June 2015    General neurology
Patients with progressive multiple sclerosis and their clinicians see clear improvements during treatment with a high dose of biotin, show further results from the phase III trial of the therapy.
22 June 2015    General neurology
Prolonged-release combined oxycodone/naloxone may provide relief for patients with severe pain related to Parkinson’s disease, a double-blind randomised trial shows.

Olivia MontuschimedwireNews Interviews
We talked to Olivia Montuschi from the Donor Conception Network about her experiences with the so-called shortage of egg and sperm donors in the UK, the possibility of intrafamilial gamete donation as a solution, and her views on the issues it raises.

View Expert Interviews

Highlights from the European Multidisciplinary Cancer Congress comprising topical discussion from key leaders in the field of oncology

Watch the latest medwireNews expert interview >


This site complies with the HONcode standard for trustworthy health information: verify here

Friendly links

Follow me on Twitter